MersV1, PubMed, Corpus, bibRecord, 000B80

Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.

Identifieur interne : 000B80 ( PubMed/Corpus ); précédent : 000B79; suivant : 000B81

Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.

Auteurs : Joel N. Maslow

Source :

Human vaccines & immunotherapeutics [ 2164-554X ] ; 2017.

RBID : pubmed:28846484

English descriptors

KwdEn :
- Communicable Diseases, Emerging (prevention & control), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Drug Discovery (methods), Drug Discovery (organization & administration), Humans, Middle East Respiratory Syndrome Coronavirus (immunology), Viral Vaccines (immunology), Viral Vaccines (isolation & purification), Zika Virus (immunology), Zika Virus Infection (epidemiology), Zika Virus Infection (prevention & control).
MESH :
- chemical , immunology : Viral Vaccines.
- epidemiology : Coronavirus Infections, Zika Virus Infection.
- immunology : Middle East Respiratory Syndrome Coronavirus, Zika Virus.
- chemical , isolation & purification : Viral Vaccines.
- methods : Drug Discovery.
- organization & administration : Drug Discovery.
- prevention & control : Communicable Diseases, Emerging, Coronavirus Infections, Zika Virus Infection.
- Humans.

Abstract

The past decade and a half has been characterized by numerous emerging infectious diseases. With each new threat, there has been a call for rapid vaccine development. Pathogens such as the Middle East Respiratory Syndrome coronavirus (MERS-CoV) and the Zika virus represent either new viral entities or viruses emergent in new geographic locales and characterized by novel complications. Both serve as paradigms for the global spread that can accompany new pathogens. In this paper, we review the epidemiology and pathogenesis of MERS-CoV and Zika virus with respect to vaccine development. The challenges in vaccine development and the approach to clinical trial design to test vaccine candidates for disease entities with a changing epidemiology are discussed.

DOI: 10.1080/21645515.2017.1358325
PubMed: 28846484

Links to Exploration step

pubmed:28846484

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.</title>
<author><name sortKey="Maslow, Joel N" sort="Maslow, Joel N" uniqKey="Maslow J" first="Joel N" last="Maslow">Joel N. Maslow</name>
<affiliation><nlm:affiliation>a GeneOne Life Science, Inc. Seoul , Korea.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28846484</idno>
<idno type="pmid">28846484</idno>
<idno type="doi">10.1080/21645515.2017.1358325</idno>
<idno type="wicri:Area/PubMed/Corpus">000B80</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B80</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.</title>
<author><name sortKey="Maslow, Joel N" sort="Maslow, Joel N" uniqKey="Maslow J" first="Joel N" last="Maslow">Joel N. Maslow</name>
<affiliation><nlm:affiliation>a GeneOne Life Science, Inc. Seoul , Korea.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Human vaccines & immunotherapeutics</title>
<idno type="eISSN">2164-554X</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Communicable Diseases, Emerging (prevention & control)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Drug Discovery (methods)</term>
<term>Drug Discovery (organization & administration)</term>
<term>Humans</term>
<term>Middle East Respiratory Syndrome Coronavirus (immunology)</term>
<term>Viral Vaccines (immunology)</term>
<term>Viral Vaccines (isolation & purification)</term>
<term>Zika Virus (immunology)</term>
<term>Zika Virus Infection (epidemiology)</term>
<term>Zika Virus Infection (prevention & control)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Zika Virus Infection</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Middle East Respiratory Syndrome Coronavirus</term>
<term>Zika Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Discovery</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Drug Discovery</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Coronavirus Infections</term>
<term>Zika Virus Infection</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The past decade and a half has been characterized by numerous emerging infectious diseases. With each new threat, there has been a call for rapid vaccine development. Pathogens such as the Middle East Respiratory Syndrome coronavirus (MERS-CoV) and the Zika virus represent either new viral entities or viruses emergent in new geographic locales and characterized by novel complications. Both serve as paradigms for the global spread that can accompany new pathogens. In this paper, we review the epidemiology and pathogenesis of MERS-CoV and Zika virus with respect to vaccine development. The challenges in vaccine development and the approach to clinical trial design to test vaccine candidates for disease entities with a changing epidemiology are discussed.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28846484</PMID>
<DateCompleted><Year>2018</Year>
<Month>07</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>01</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>13</Volume>
<Issue>12</Issue>
<PubDate><Year>2017</Year>
<Month>12</Month>
<Day>02</Day>
</PubDate>
</JournalIssue>
<Title>Human vaccines & immunotherapeutics</Title>
<ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
</Journal>
<ArticleTitle>Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.</ArticleTitle>
<Pagination><MedlinePgn>2918-2930</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2017.1358325</ELocationID>
<Abstract><AbstractText>The past decade and a half has been characterized by numerous emerging infectious diseases. With each new threat, there has been a call for rapid vaccine development. Pathogens such as the Middle East Respiratory Syndrome coronavirus (MERS-CoV) and the Zika virus represent either new viral entities or viruses emergent in new geographic locales and characterized by novel complications. Both serve as paradigms for the global spread that can accompany new pathogens. In this paper, we review the epidemiology and pathogenesis of MERS-CoV and Zika virus with respect to vaccine development. The challenges in vaccine development and the approach to clinical trial design to test vaccine candidates for disease entities with a changing epidemiology are discussed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maslow</LastName>
<ForeName>Joel N</ForeName>
<Initials>JN</Initials>
<AffiliationInfo><Affiliation>a GeneOne Life Science, Inc. Seoul , Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>08</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Hum Vaccin Immunother</MedlineTA>
<NlmUniqueID>101572652</NlmUniqueID>
<ISSNLinking>2164-5515</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="N">Zika Virus Infection</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">DNA vaccine</Keyword>
<Keyword MajorTopicYN="Y">MERS-CoV</Keyword>
<Keyword MajorTopicYN="Y">Zika virus</Keyword>
<Keyword MajorTopicYN="Y">coronavirus</Keyword>
<Keyword MajorTopicYN="Y">emerging infectious disease</Keyword>
<Keyword MajorTopicYN="Y">epidemic</Keyword>
<Keyword MajorTopicYN="Y">epidemiology</Keyword>
<Keyword MajorTopicYN="Y">flavivirus</Keyword>
<Keyword MajorTopicYN="Y">vaccine</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>8</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2018</Year>
<Month>7</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>8</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28846484</ArticleId>
<ArticleId IdType="doi">10.1080/21645515.2017.1358325</ArticleId>
<ArticleId IdType="pmc">PMC5718785</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Bull World Health Organ. 1964;31:57-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14230895</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1952 Aug;69(2):223-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14946416</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2004 Mar 15;189(6):990-1000</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14999601</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2005 Aug 1;192(3):510-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15995967</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2007;315:325-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17848070</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2007 Oct;13(10):1562-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18258008</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1977 Jul 1;146(1):218-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">195000</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Jun 11;360(24):2536-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19516034</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2010 Sep;84(18):9318-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20610717</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2011 Jun 15;186(12):7264-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21576510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2011 Dec;85(23):12201-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21937658</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2012 Sep 27;17(39):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23041020</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2012 Nov 20;3(6):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23170002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2013 Mar 14;495(7440):251-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23486063</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2013 Jun 29;381(9885):2265-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23727167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):480-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23760190</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Aug 1;369(5):407-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23782161</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2014 Feb 1;209(3):360-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23964110</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Oct 31;369(18):1761</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24171525</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2013 Nov;19(11):1819-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24206838</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2014 Mar 18;160(6):389-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24474051</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2014 Feb 18;5(1):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24549846</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 May;88(9):4953-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24554656</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4970-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24599590</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2014 Mar 06;19(9):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24626205</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2014 Apr;20(4):552-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24655412</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2014 Apr;20(4):560-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24655427</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2014 Apr 03;19(13):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24721538</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2014 May 30;32(26):3169-3174</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24736006</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2014 Jun;20(6):1085-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24856001</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2014 Jun 26;370(26):2499-505</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24896817</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Aug;88(16):9220-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24899185</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2014 Oct;20(10):O595-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24909208</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2014 Jul;20(7):1231-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24964193</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Oct;88(19):11034-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25056892</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2014 Aug;20(8):1370-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25062254</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12516-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25114257</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2014 Aug 21;10(8):e1004250</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25144235</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2014 Aug 28;371(9):828-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25162889</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2014 Oct 14;32(45):5975-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25192975</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2014 Sep 10;16(3):328-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25211075</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2014 Oct 2;371(14):1359-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25271615</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Negl Trop Dis. 2014 Oct 09;8(10):e3188</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25299181</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 Oct 13;9(10):e109442</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25310102</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 Nov 18;9(11):e112602</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25405618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2014 Dec;20(12):1999-2005</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25418529</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2015 Apr 16;202:151-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25445336</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2015 Mar;9(2):64-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25470665</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2015 Jan;21(1):84-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25530324</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2015 Apr;89(7):3659-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25589660</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2015 Feb;21(2):359-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25625872</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Genes. 2015 Jun;50(3):509-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25653016</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2015 Apr;21(4):699-701</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25811546</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2015 Aug;89(16):8651-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26018172</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2015 Jul;68:53-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26071336</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sex Transm Infect. 2015 Aug;91(5):359</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26113729</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8738-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26124093</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Ecol Epidemiol. 2015 Jul 15;5:28305</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26183160</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2015 Oct;122:28-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26192750</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Commun. 2015 Jul 28;6:7712</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26218507</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Transbound Emerg Dis. 2017 Apr;64(2):344-353</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26256102</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Transl Med. 2015 Aug 19;7(301):301ra132</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26290414</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2015 Nov;485:422-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26342468</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2015 Nov;89(22):11654-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26355094</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2015 Oct;21(10):1885-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26401719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2015 Oct 07;90(1):57-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26446606</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2015 Nov;21(11):2029-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26488195</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2015 Nov;21(11):2088-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26488869</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Korean Med Sci. 2015 Nov;30(11):1701-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26539018</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2016 Feb 15;62(4):477-483</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26565003</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2015 Dec;21(12):2186-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26583829</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2015 Dec;21(12):2274-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26584464</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Prev Med Public Health. 2015 Nov;48(6):274-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26639740</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2016 Jan;22(1):32-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26692003</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2015 Dec 23;10(12):e0145561</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26701103</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Health. 2015 Sep 17;37:e2015041</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26725225</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Negl Trop Dis. 2016 Mar 03;10(3):e0004543</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26938868</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2016 Dec 15;375(24):2321-2334</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26943629</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2016 Apr 9;387(10027):1531-1539</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26948433</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2016 Apr 21;374(16):1595-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26958738</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2016 Oct;88(10):1703-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26990973</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2016 Jul 15;63(2):227-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27048745</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2016;21(13):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27063794</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2016 Jun;22(6):1129-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27070501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2016 Jun;22(6):1071-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27070733</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2016 May;22(5):940</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27088817</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Trop Med Hyg. 1989 Apr;40(4):444-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2712199</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2016 Apr 21;21(16):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27126052</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2016 May 13;65(18):475-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27171533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2016 Jun 8;19(6):882-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27212660</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemics. 2016 Jun;15:66-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27288540</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2016 Oct;22(10):1824-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27332149</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2016 Aug 4;536(7614):48-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27338953</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2016 Sep;17(9):1102-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27339099</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2016 Aug 25;536(7617):474-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27355570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2016 Jul 7;22(7):701-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27387881</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2016 Sep;82:1-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27389909</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2016 Aug 19;353(6301):823-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27417494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2016 Oct;22(10):1857-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27434194</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2016 Aug;22(8):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27439020</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2016 Oct;22(10):1813-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27479636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Obstet Gynecol. 2016 Oct;128(4):724-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27479770</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2016 Sep 9;353(6304):1129-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27492477</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Stem Cell. 2016 Nov 3;19(5):663-671</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27524440</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Trop Med Hyg. 2016 Nov 2;95(5):1169-1173</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27573623</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2016 Oct 20;375(16):1598-1601</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27579558</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2016 Sep 02;65(34):915-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27585037</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2016 Sep 02;65(34):917-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27585248</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2016 Nov;22(11):1894-1899</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27603576</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2016 Nov;22(11):1256-1259</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27618651</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2016 Sep 22;375(12):1202-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27653589</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2016 Oct 14;354(6309):237-240</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27708058</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EBioMedicine. 2016 Nov;13:315-320</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27717627</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EBioMedicine. 2016 Nov;13:29-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27751766</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2016 Dec 15;540(7633):438-442</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27798603</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Microbiol. 2016 Oct 24;7:1685</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27822207</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Commun. 2016 Nov 22;7:13473</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27874853</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2017 Feb 4;389(10068):505-518</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28017403</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Transl Immunology. 2016 Dec 16;5(12):e117</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28090318</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2017 Mar 9;543(7644):248-251</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28151488</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2017 Feb 2;13(2):e1006164</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28152048</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2017 Oct 4;35(41):5437-5443</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28216184</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2017 Mar 9;168(6):1114-1125.e10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28222903</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2017 Mar 14;35(12):1586-1589</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28237499</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2017 Apr 11;35(16):2069-2075</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28314561</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2017 May 1;198(9):3526-3535</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28330900</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2017 Mar 23;7:44875</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28332568</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2017 Apr 14;356(6334):175-180</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28360135</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2017 Apr 7;14(1):70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28388922</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2017 Jun;23(6):763-767</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28394328</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2017 Apr 20;376(16):1591-1593</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28402236</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2017 May;23(5):773-781</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28418292</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2017 May 4;169(4):610-620.e14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28457610</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2017 May 04;169(4):597-609.e11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28475892</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2017 Sep 15;65(6):877-883</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28535184</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>NPJ Vaccines. 2016 Nov 10;1:16021</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29263859</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cytobios. 1987;49(196):49-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3028713</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull Soc Pathol Exot Filiales. 1978 Mar-Apr;71(2):131-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33772</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1977 Jul 1;146(1):201-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">406347</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hyg (Lond). 1979 Oct;83(2):213-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">489960</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Trop Med Hyg. 1969 May;18(3):411-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4976739</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Trop Med Hyg. 1970 Jan;19(1):110-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4984581</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Gesamte Virusforsch. 1971;35(2):183-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5002906</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull World Health Organ. 1970;43(4):539-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5313066</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1982 Jun;36(3):1036-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6284641</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B80 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000B80 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:28846484
   |texte=   Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:28846484" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021

	Serveur d'exploration MERS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration MERS

Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.

Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki